What is stem cell?
- Body “MASTER” cells in human body.
- Capable of SELF RENEWAL –> make more stem cells –> to replenish and repair tissue
- Capable of DIFFERENTIATION –> different types of cells.
What are stem cells therapies?
- The treatment of various disorders, non-serious to life threatening, by using stem cells.
Mesenchymal Stem Cell (MSC) & Its Role in Stem Cell Therapy
Mesenchymal Stem Cell (MSC)
- In year 2006, human MSCs are defined by the International Society for Cellular Therapy (ISCT) as below: –
- Plastic adherent.
- Possess specific surface markers (CD105+, CD73+, CD90+, CD45-, CD34-, CD14-, CD11b-, CD79a-, CD19- and HLA-DR-).
-
Capable of differentiating into: –
- osteoblasts (bone cells)
- adipocytes (fat cells)
- chondroblasts (cartilage)
Where can we find MSC?
Mesenchymal stem cells (MSC) are multipotent stem cells that could differentiate into multiple lineages including osteogenic (bone cells), adipogenic (fat cells), chondrogenic (cartilage) and neurogenic (nerve cells).
The most common sources of MSC in the body are bone marrow, umbilical cord, adipose tissues, dental pulp, and peripheral blood.
Multipotency of MSC
MSCs vs Other Types of Stem Cells
MSCs vs Other types of Stem Cells
MSC Therapeutic Applications
Potential MSC Therapies:
- Graft versus Host Disease (following transplantation)
- Tissue/ organ repair (Bone, cartilages, cardiac and brain)
- Diabetes
- Ageing-related
- Weakness
Clinical Trials with MSC (1)
MSC vs aGvHD/HSC transplantation
Clinical Trials with MSC (2)
MSC vs aGvHD/HSC transplantation
Clinical Trials with MSC (3)
MSC vs Osteoarthritis
Clinical Trials with MSC (4)
MSC vs Diabetic foot ulcer
Clinical Trials with MSC (5)
MSC vs Aging Frailty
Aging frailty:
- Characterized by decreased physical and immunological functioning.
- Associated with stem cell depletion.
- Randomized, double-blinded study
- Patients with frailty (n=30, mean age 75.5 ± 7.3 yrs old)
- Intravenous injection of allo-hMSCs (100 or 200 million cells)
- Research findings:
–> After 1 month: No adverse effects
–> After 6 months:
√ 6-min walk test, short physical performance exam, and forced expiratory volume in 1 second test ↑
√ Female sexual quality of life questionnaire ↑
√ Inflammation marker (TNF-a) ↓
Challenges of MSC Therapeutic Applications
SAFETY
- Ethical approval
- Standard
→ cGMP stem cell production laboratory
- Regulation and Law Enforcement
→ National Pharmaceutical Regulatory Agency (NPRA)
→ Medical Review & Ethics Committee (MREC)
→ Institutional Review Board
Challenges of MSC Therapeutic Applications
EFFICACY
Therapeutic effects
The Sciences